Literature DB >> 11584382

Woodchuck hepatocytes remain permissive for hepadnavirus infection and mouse liver repopulation after cryopreservation.

M Dandri1, M R Burda, A Gocht, E Török, J M Pollok, C E Rogler, H Will, J Petersen.   

Abstract

Isolated hepatocytes represent a relevant model of the liver and are highly required both for research and therapeutic applications. However, sources of primary liver cells from human beings and from some animal species are limited. Therefore, cryopreservation of hepatocytes could greatly facilitate advances in various research areas. The aim of this study was to evaluate whether cryopreserved primary woodchuck hepatocytes could be used for woodchuck hepatitis B virus (WHV) infection studies, and whether they could maintain their regenerative potential in vivo after thawing. Critical steps for good quality of cryopreserved hepatocytes included the use of University of Wisconsin (UW) solution as a main component of the freezing medium, stepwise reduction of dimethylsulfoxide (DMSO) to avoid osmotic shock, and maintenance of low concentrations of DMSO in the culture medium. After cryopreservation, cell viability was still high (70% to 80%), and 50% to 60% of thawed cells attached to the plates. The appearance of covalently closed circular (ccc)DNA and of WHV-replicative forms a few days after in vitro infection demonstrated that thawed woodchuck hepatocytes were still susceptible to viral infection, thus proving maintenance of a very high hepatocyte-specific differentiation status. Furthermore, transplantation of woodchuck hepatocytes into the liver of urokinase-type plasminogen activator (uPA)/recombination activation gene-2 (RAG-2) mice, a model of liver regeneration, demonstrated that cryopreserved cells retained the ability to divide and to extensively repopulate a xenogenic liver. Notably, in vivo susceptibility to infection with WHV and proliferative capacity of frozen/thawed woodchuck hepatocytes in recipient mice were identical to those observed by transplanting fresh hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11584382     DOI: 10.1053/jhep.2001.28189

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

Review 1.  Hepatocyte cryopreservation: is it time to change the strategy?

Authors:  Xavier Stéphenne; Mustapha Najimi; Etienne M Sokal
Journal:  World J Gastroenterol       Date:  2010-01-07       Impact factor: 5.742

2.  Hepatic hyperplasia associated with discordant xenogeneic parenchymal-nonparenchymal interactions in human hepatocyte-repopulated mice.

Authors:  Rie Utoh; Chise Tateno; Miho Kataoka; Asato Tachibana; Norio Masumoto; Chihiro Yamasaki; Takashi Shimada; Toshiyuki Itamoto; Toshimasa Asahara; Katsutoshi Yoshizato
Journal:  Am J Pathol       Date:  2010-06-03       Impact factor: 4.307

Review 3.  Experimental models and therapeutic approaches for HBV.

Authors:  Maura Dandri; Marc Lütgehetmann; Jörg Petersen
Journal:  Semin Immunopathol       Date:  2012-08-17       Impact factor: 9.623

4.  Proliferation of L02 human hepatocytes in tolerized genetically immunocompetent rats.

Authors:  Hu Lin; Qing Mao; Yu-Ming Wang; Li Jiang
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

Review 5.  New animal models for hepatitis C viral infection and pathogenesis studies.

Authors:  Dina Kremsdorf; Nicolas Brezillon
Journal:  World J Gastroenterol       Date:  2007-05-07       Impact factor: 5.742

Review 6.  Experimental models of hepatitis B and C - new insights and progress.

Authors:  Emmanuel Thomas; T Jake Liang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-14       Impact factor: 46.802

7.  HCV animal models: a journey of more than 30 years.

Authors:  Philip Meuleman; Geert Leroux-Roels
Journal:  Viruses       Date:  2009-09-02       Impact factor: 5.048

8.  Primary Human Hepatocytes Repopulate Livers of Mice After In Vitro Culturing and Lentiviral-Mediated Gene Transfer.

Authors:  Jeanette Bierwolf; Tassilo Volz; Marc Lütgehetmann; Lena Allweiss; Kristoffer Riecken; Michael Warlich; Boris Fehse; Joerg C Kalff; Maura Dandri; Joerg-Matthias Pollok
Journal:  Tissue Eng Part A       Date:  2016-05       Impact factor: 3.845

9.  Cryopreservation of Hepatocyte Microbeads for Clinical Transplantation.

Authors:  Suttiruk Jitraruch; Anil Dhawan; Robin D Hughes; Celine Filippi; Sharon C Lehec; Leanne Glover; Ragai R Mitry
Journal:  Cell Transplant       Date:  2017-08       Impact factor: 4.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.